首页 | 本学科首页   官方微博 | 高级检索  
检索        

不同剂量西酞普兰抗抑郁疗效及安全性比较
引用本文:章华,成敬.不同剂量西酞普兰抗抑郁疗效及安全性比较[J].临床精神医学杂志,2005,15(5):275-276.
作者姓名:章华  成敬
作者单位:430060,武汉大学人民医院精神卫生中心
摘    要:目的:比较不同剂量西酞普兰治疗抑郁障碍的疗效及不良反应. 方法:将抑郁发作的患者分别用西酞普兰20 mg/d、 40 mg/d,治疗6周.采用汉密尔顿抑郁量表(HAMD)、临床疗效总评量表(CGI)、副反应量表(TESS)评定疗效及不良反应. 结果:31例完成6周观察,20 mg组14例,40 mg组17例.两组有效率和痊愈率差异无显著性.阻滞因子的改善20 mg组显著好于40 mg组.焦虑因子的改善40 mg组显著好于20 mg组.两组不良反应差异无显著性. 结论:西酞普兰20 mg/d、 40 mg/d均有很好的抗抑郁疗效,不良反应轻微,耐受性好.

关 键 词:西酞普兰  剂量  抑郁障碍
文章编号:1005-3220(2005)05-0275-02
收稿时间:2005-01-14
修稿时间:2005年1月14日

Therapeutic effect and security in depressive patients with various doses of citalopram
ZHANG Hua,CHENG Jing.Therapeutic effect and security in depressive patients with various doses of citalopram[J].Journal of Clinical Psychological Medicine,2005,15(5):275-276.
Authors:ZHANG Hua  CHENG Jing
Abstract:Objective:To compare the efficacy and security of various doses of citalopram to the depressive patients. Method:Patients with depressive episode were orally administered citalopram 20 mg/d or 40 mg/d respectively for six weeks.Hamilton depression rating scale(HAMD),clinical general impressional scale(CGI)and treatment emergent symptom scale(TESS) were assessed. Results:31 patients were observed for 6 weeks,14 patients were treated by 20 mg/d and 17 patients were treated by 40 mg/d.The efficacy rate and the recovery rate of the 20 mg/d group and 40 mg/d had no remarkabled difference,retarded factor of HAMD was significantly better in 20 mg/d group than 40 mg/d group.Anxiety factor was significantly better in 40 mg/d group than 20 mg/d group.There was no significant difference between the adverse reaction rate of two groups. Conclusion:Citalopram shows excellent therapeutic effect for depressive patients both in 20 mg/d and in 40 mg/d and also has little adverse effect which is easy to be tolreant.
Keywords:citalopram  dose  depressive disorder
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号